Prediction of Preeclampsia and Delivery of Small for Gestational Age Babies Based on a Combination of Clinical Risk Factors in High-Risk Women

REFERENCES

• Milne F, Redman C, Walker J, The pre-eclampsia community guideline (PRECOG): How to screen for and detect onset of pre-eclampsia in the community. BMJ 2005; 330:576–580.
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ 2005; 330:565.
   PubMed Web of Science ®Google Scholar
• Yu CK, Teoh TG, Robinson S. Obesity in pregnancy. Br J Obstet Gynaecol 2006; 113:1117–1125.
   Google Scholar
• McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996; 103:123–129.
   PubMedGoogle Scholar
• Papageorghiou AT, Yu CK, Erasmus IE, Cuckle HS, Nicolaides KH. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005; 112:703–709.
   PubMed Web of Science ®Google Scholar
• Coleman MA, McCowan LM, North RA. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women. Ultrasound Obstet Gynecol 2000; 15:7–12.
   PubMed Web of Science ®Google Scholar
• Toal M, Chan C, Fallah S, Usefulness of a placental profile in high-risk pregnancies. Am J Obstet Gynecol 2007; 196:363.e361–367.
   Google Scholar
• O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: A systematic overview. Epidemiology 2003; 14:368–374.
   PubMed Web of Science ®Google Scholar
• LaCoursiere DY, Bloebaum L, Duncan JD, Varner MW. Population-based trends and correlates of maternal overweight and obesity, Utah 1991–2001. Am J Obstet Gynecol 2005; 192:832–839.
   PubMed Web of Science ®Google Scholar
• Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in pre-eclampsia Trial C. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial. Lancet 2006; 367:1145–1154.
   Google Scholar
• Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol 1983; 61:571–576.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Lindheimer M, Hauth J, Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 339:667–671.
   PubMed Web of Science ®Google Scholar
• Zetterstrom K, Lindeberg SN, Haglund B, Hanson U. Maternal complications in women with chronic hypertension: A population-based cohort study. Acta Obstet Gynecol Scand 2005; 84:419–424.
   PubMed Web of Science ®Google Scholar
• Campbell DM, MacGillivray I, Carr-Hill R. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol 1985; 92:131–140.
   PubMedGoogle Scholar
• Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim BI, Eskild A. Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet A 2004; 126A:41–45.
   PubMed Web of Science ®Google Scholar
• Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155:1011–1016.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. [Update of Cochrane Database Syst Rev 2004; (1):CD004659; PMID: 14974075.] Cochrane Database Syst Rev 2007; CD004659.
   Google Scholar
• Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, Group PC. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. [See comment.] Lancet 2007; 369:1791–1798.
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX–XIV.
   PubMed Web of Science ®Google Scholar
• Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 1995; 6:168–174.
   PubMed Web of Science ®Google Scholar
• Pickard RR, Cook RD. Cross-validation of regression models. J Am Stat Assoc 1984; 79:575–583.
   Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr 1974; 19:716–723.
   Web of Science ®Google Scholar
• Breiman L, Friedman J, Olshen R, Stone C. Classification and Regression Trees. New York: Chapman and Hall, 1993.
   Google Scholar
• Kasabov N. Evolving Connectionist Systems. New York: Springer, 2003.
   Google Scholar
• Armitage P, Berry G. Chapter 2: Probability. In: Armitage P, Berry G. Statistical Methods for Medical Research. Oxford: Blackwell Scientific Publications, 1987:42–76.
   Google Scholar
• National Screening Committee. Second Report of the UK National Screening Committee. Department of Health, The Scottish Executive, Social Serivces and Public Safety, Northern Ireland and The National Assembly for Wales.UK, 2000.
   Google Scholar
• Kanagalingam MG, Forouhi NG, Greer IA, Sattar N. Changes in booking body mass index over a decade: Retrospective analysis from a Glasgow Maternity Hospital. BJOG 2005; 112:1431–1433.
   PubMed Web of Science ®Google Scholar
• Mostello D, Catlin TK, Roman L, Holcomb WL, Jr, Leet T. Preeclampsia in the parous woman: Who is at risk? Am J Obstet Gynecol 2002; 187:425–429.
   PubMed Web of Science ®Google Scholar
• Rajasingam D, Seed PT, Briley AL, Shennan AH, Poston L. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol 2009; 200:395.e1–9.
   PubMed Web of Science ®Google Scholar
• Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 2005; 193:429–436.
   PubMed Web of Science ®Google Scholar
• Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002; 359:881–884.
   PubMed Web of Science ®Google Scholar
• Lydon-Rochelle MT, Holt VL, Cardenas V, The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol 2005; 193:125–134.
   PubMed Web of Science ®Google Scholar
• Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertens Pregnancy 2009; 28:417–434.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: A prospective study. Hypertension 2008; 51:1002–1009.
   PubMed Web of Science ®Google Scholar
• August P, Helseth G, Cook EF, Sison C. A prediction model for superimposed preeclampsia in women with chronic hypertension during pregnancy. Am J Obstet Gynecol 2004; 191:1666–1672.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Seed PT, Briley A, A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187:127–136.
   PubMed Web of Science ®Google Scholar